These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27610375)

  • 1. Integrated Analysis of DNA Methylation and mRNA Expression Profiles Data to Identify Key Genes in Lung Adenocarcinoma.
    Jin X; Liu X; Li X; Guan Y
    Biomed Res Int; 2016; 2016():4369431. PubMed ID: 27610375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a 26‑feature gene support vector machine classifier for smoking and non‑smoking lung adenocarcinoma sample classification.
    Yang L; Sun L; Wang W; Xu H; Li Y; Zhao JY; Liu DZ; Wang F; Zhang LY
    Mol Med Rep; 2018 Feb; 17(2):3005-3013. PubMed ID: 29257283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
    Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
    BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of differentially expressed genes between lung adenocarcinoma and lung squamous cell carcinoma by gene expression profiling.
    Lu C; Chen H; Shan Z; Yang L
    Mol Med Rep; 2016 Aug; 14(2):1483-90. PubMed ID: 27356570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of stage-specific biomarkers in lung adenocarcinoma based on RNA-seq data.
    Liang J; Lv J; Liu Z
    Tumour Biol; 2015 Aug; 36(8):6391-9. PubMed ID: 25861020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma.
    Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY
    Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of crucial genes associated with lung adenocarcinoma by bioinformatic analysis.
    Dai JJ; Zhou WB; Wang B
    Medicine (Baltimore); 2020 Oct; 99(44):e23052. PubMed ID: 33126397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of differential protein-coding gene expressions in early phase lung adenocarcinoma.
    Zhou LN; Li SC; Li XY; Ge H; Li HM
    Thorac Cancer; 2018 Feb; 9(2):234-240. PubMed ID: 29266838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma.
    Zeng Y; He T; Liu J; Li Z; Xie F; Chen C; Xing Y
    Medicine (Baltimore); 2020 Nov; 99(47):e23314. PubMed ID: 33217867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis of the gene expression profile and DNA methylation profile of obese patients with type 2 diabetes.
    Shen J; Zhu B
    Mol Med Rep; 2018 Jun; 17(6):7636-7644. PubMed ID: 29620215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis.
    Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X
    Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key DNA methylation-driven genes in prostate adenocarcinoma: an integrative analysis of TCGA methylation data.
    Xu N; Wu YP; Ke ZB; Liang YC; Cai H; Su WT; Tao X; Chen SH; Zheng QS; Wei Y; Xue XY
    J Transl Med; 2019 Sep; 17(1):311. PubMed ID: 31533842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of key genes associated with non-small-cell lung cancer.
    Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
    J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
    Liu X; Liu X; Li J; Ren F
    Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling analysis of lung adenocarcinoma.
    Xu H; Ma J; Wu J; Chen L; Sun F; Qu C; Zheng D; Xu S
    Braz J Med Biol Res; 2016 Mar; 49(3):. PubMed ID: 26840709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis reveals candidate genes and transcription factors in lung adenocarcinoma.
    Chen B; Gao S; Ji C; Song G
    Mol Med Rep; 2017 Dec; 16(6):8371-8379. PubMed ID: 28983631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Landscape of epigenetically regulated lncRNAs and DNA methylation in smokers with lung adenocarcinoma.
    Jung J; Lee YJ; Kim CH; Ahn S
    PLoS One; 2021; 16(3):e0247928. PubMed ID: 33684161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of lung adenocarcinoma biomarkers based on bioinformatic analysis and human samples.
    Dong S; Men W; Yang S; Xu S
    Oncol Rep; 2020 May; 43(5):1437-1450. PubMed ID: 32323809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.